Cite

HARVARD Citation

    Zeng, J. et al. (2017). Assessing the clinical outcome of nab‐paclitaxel in Chinese patients with advanced non‐small‐cell lung cancer. Clinical respiratory journal. pp. 632-639. [Online]. 
  
Back to record